Nanomedicine Scale-Up Technologies

Nanomedicine refers to the use of nanostructures, including nanoparticles, nanoclusters, nanospheres, and nanosized drugs, vaccines, and DNA, to enhance therapeutic and diagnostic outcomes in biomedical and pharmaceutical applications. These nanostructures are deliberately developed through micro or macro-systems for better outcomes. In this sense, nanomedicines’ size, shape, morphological properties, size distribution, target ability, and mode of operation are all crucial for biomedical applications such as early identification of life-threatening conditions or for the regulated delivery of bioactive ingredients using nano devices to combat disease or disorders. On the other hand, a predictable medication release profile is necessary to ensure uniformity and quality. The technique is governed by the desired application, the material, and its bioactive properties. Regulatory guidelines should be governed to ensure purity and safety. Emerging techniques, such as membrane extrusion, supercritical fluid technology, and micro-fluidizer technology, have the potential for scaling-up, but their application to large-scale targeted and surface-functionalized nanoparticles is uncertain. This chapter enables contemporary advancements in nanoparticle production processes, including scaling-up procedures, industrial applications, and the obstacles associated with their scale-up process and their usage as nanomedicine.